Notificación de defectos congénitos y uso de didrogesterona: Un análisis de desproporcionalidad a partir de la base de datos de farmacovigilancia de la Organización Mundial de la Salud (VigiBase)

A Henry; M Bourdon; C Maignien; C Chapron; JM Treluyer; J Guibourdenche; L Chouchana

Vol. 32 No. 2 (2025), Bibliographic novelty

Vol. 32 No. 2 (2025)

Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase)

Bibliographic novelty

Published 2025-07-09

A Henry⁺⁻
M Bourdon⁺⁻
C Maignien⁺⁻
C Chapron⁺⁻
JM Treluyer⁺⁻
J Guibourdenche⁺⁻
L Chouchana⁺⁻

A Henry

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828.

M Bourdon

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828.

C Maignien

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828.

C Chapron

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828.

JM Treluyer

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828. Revista de

J Guibourdenche

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828. Revista de

L Chouchana

Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. PMID: 39807112; PMCID: PMC11726828. Revista de

pdf (Español (España))

html (Español (España))

Keywords

dydrogesterone

How to Cite

1.

Henry A, Bourdon M, Maignien C, Chapron C, Treluyer J, Guibourdenche J, Chouchana L. Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). RSAEGRE [Internet]. 2025 Jul. 9 [cited 2026 May 7];32(2):58-60. Available from: https://revistasaegre.com.ar/index.php/revista/article/view/51